diagnostics

Premium

Healthcare

06 November, 2020

How Bengaluru-based pathology firm is valued as it attracts big buyer

A Bengaluru-based diagnostics company has attracted a big publicly listed buyer which seeks to expand its presence in the southern ......

Premium

Healthcare

30 October, 2020

Sector watch: Will COVID-19 strengthen big diagnostics firms, spur consolidation?

When Nalanda Capital bet on Thyrocare Technologies Ltd in March, the private equity-style investor in public equities was likely enticed ......

Premium

Healthcare

12 October, 2020

Healthcare PE deals fall from perch in July-Sept, M&As little changed

The number of private equity deals in India’s healthcare sector dropped in the July-September period to their lowest level in ......

Premium

Healthcare

11 September, 2020

Nalanda Capital-backed Thyrocare to appoint first new CEO in 25 years

Thyrocare Technologies Ltd, which has been led since 1995 by founder Arokiaswamy Velumani, is set to get a new chief ......

Premium

Healthcare

02 July, 2020

Metropolis Healthcare's deal to acquire Gujarat diagnostics firm collapses

Pathology chain Metropolis Healthcare Ltd’s plan to acquire a majority stake in a Gujarat-based diagnostics company has fallen through. Metropolis had, ......

Premium

Healthcare

01 July, 2020

PE-backed specialised diagnostics firm Lilac eyes fresh funding for expansion

Specialised diagnostics company Lilac Insights Pvt. Ltd, which had raised its first private equity funding three years ago, is looking ......

Premium

Healthcare

06 April, 2020

COVID-19 tests to be small part of biz, won't delight investors: Thyrocare founder

Last month, the Indian government allowed some accredited private labs to test coronavirus samples. The move was seen as a ......

Premium

Healthcare

26 March, 2020

Nalanda sniffs opportunity in coronavirus outbreak, makes first-ever healthcare bet

Nalanda Capital, an India-focused private equity-style investor in public equities, has bought a minority stake in a diagnostics services provider ......

Premium

Healthcare

16 March, 2020

Coronavirus: Pathology chains wait on the sidelines, device makers gear up

The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last week, ......

Premium

Healthcare

09 March, 2020

Sector Watch: How PE-backed regional pathology chains stack up versus national peers

A few months after Thyrocare Technologies Ltd made a spectacular debut on stock exchanges, its founder A Velumani predicted that ......